Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Published in: International Journal of Clinical Oncology 4/2006

01-08-2006 | ORIGINAL ARTICLE

A randomized comparative study of endocrine monotherapy and a combination of estramustine phosphate with the endocrine therapy in patients with untreated stage D prostate cancer

Authors: Senji Hoshi, Osamu Yamaguchi, Tomoaki Fujioka, Yoichi Arai, Yoshihiko Tomita, Tomonori Habuchi, Chikara Ohyama, Tadashi Suzuki, Seiichi Orikasa, The Tohoku Prostate Cancer Study Group

Published in: International Journal of Clinical Oncology | Issue 4/2006

Login to get access
Metadata
Title
A randomized comparative study of endocrine monotherapy and a combination of estramustine phosphate with the endocrine therapy in patients with untreated stage D prostate cancer
Authors
Senji Hoshi
Osamu Yamaguchi
Tomoaki Fujioka
Yoichi Arai
Yoshihiko Tomita
Tomonori Habuchi
Chikara Ohyama
Tadashi Suzuki
Seiichi Orikasa
The Tohoku Prostate Cancer Study Group
Publication date
01-08-2006
Publisher
Springer-Verlag
Published in
International Journal of Clinical Oncology / Issue 4/2006
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-006-0563-8

Other articles of this Issue 4/2006

International Journal of Clinical Oncology 4/2006 Go to the issue

ORIGINAL ARTICLE

The expression of thymidine phosphorylase is a prognostic predictor for the intravesical recurrence of superficial bladder cancer

CASE REPORT

Possibility of recovery of estrogen sensitivity following high-dose glucocorticoid therapy in a patient with hormone-refractory prostate cancer

ORIGINAL ARTICLE

Serial changes of international prostate symptom score following I-125 prostate brachytherapy

REVIEW ARTICLE

Trends in oncological CT imaging: clinical application of multidetector-row CT and 3D-CT imaging

REVIEW ARTICLE

Recent applications of ultrasound: diagnosis and treatment of hepatocellular carcinoma

REVIEW ARTICLE

PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits